glp 1 agonist drugs for weight loss How GLP-1 medications are transforming diabetes and treatment The Heavy Cost of Using

Ipamorelin is a hormone secretagogue

Similar to the sodium-glucose cotransporter 2 (SGLT2) inhibitors, some glucagon-like peptide-1 receptor agonists (GLP-1RAs) have also demonstrated a marked risk reduction in major adverse CV events (MACE) in patients with type 2 diabetes at high risk of CV events

A dose that works for one person may be too much or too little for another

Hypothalamic inflammation in obesity and metabolic disease

Most new moms in the study who used a GLP-1 drug mostly semaglutide were overweight before becoming pregnant and only 23% had diabetes, suggesting they primarily used the medication for weight loss, the authors wrote